Next Article in Journal
New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors
Next Article in Special Issue
Neuropsychiatric Disorders and COVID-19: What We Know So Far
Previous Article in Journal
Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
Previous Article in Special Issue
Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454

by
Isabella Zanella
1,2,*,
Daniela Zizioli
1,
Francesco Castelli
3 and
Eugenia Quiros-Roldan
3
1
Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
2
Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy
3
University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2021, 14(8), 827; https://doi.org/10.3390/ph14080827
Submission received: 16 July 2021 / Accepted: 5 August 2021 / Published: 23 August 2021
(This article belongs to the Special Issue COVID-19 in Pharmaceuticals)
Text Correction
There was an error in the original article [1]. In the Abstract, page 1, line 12 from the top, the sentence “… remdesivir, a nucleotide analog that acts as reverse-transcriptase inhibitor, …” is incorrect.
A correction has been made to the Abstract.
The incorrect sentence must be replaced with “… remdesivir, a nucleotide analog that acts as RNA-dependent RNA-polymerase inhibitor, …”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Zanella, I.; Zizioli, D.; Castelli, F.; Quiros-Roldan, E. Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV-2 infection. Pharmaceuticals 2021, 14, 454. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zanella, I.; Zizioli, D.; Castelli, F.; Quiros-Roldan, E. Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454. Pharmaceuticals 2021, 14, 827. https://doi.org/10.3390/ph14080827

AMA Style

Zanella I, Zizioli D, Castelli F, Quiros-Roldan E. Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454. Pharmaceuticals. 2021; 14(8):827. https://doi.org/10.3390/ph14080827

Chicago/Turabian Style

Zanella, Isabella, Daniela Zizioli, Francesco Castelli, and Eugenia Quiros-Roldan. 2021. "Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454" Pharmaceuticals 14, no. 8: 827. https://doi.org/10.3390/ph14080827

APA Style

Zanella, I., Zizioli, D., Castelli, F., & Quiros-Roldan, E. (2021). Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454. Pharmaceuticals, 14(8), 827. https://doi.org/10.3390/ph14080827

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop